+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Soft Tissue Allografts - Global Market Trajectory & Analytics

  • ID: 5140778
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Alliqua BioMedical, Inc.
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • ConMed Corporation
  • Globus Medical, Inc.
  • Lattice Biologics Ltd.
Global Soft Tissue Allografts Market to Reach $6 Billion by 2027

Amid the COVID-19 crisis, the global market for Soft Tissue Allografts estimated at US$4.3 Billion in the year 2020, is projected to reach a revised size of US$6 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Orthopedic, one of the segments analyzed in the report, is projected to record a 4.9% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Dentistry segment is readjusted to a revised 5.5% CAGR for the next 7-year period.





The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 4.6% CAGR

The Soft Tissue Allografts market in the U.S. is estimated at US$1.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Wound Care Segment to Record 4.4% CAGR

In the global Wound Care segment, USA, Canada, Japan, China and Europe will drive the 4.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$1.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$689 Million by the year 2027.

Select Competitors (Total 42 Featured):
  • Alliqua BioMedical, Inc.
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • ConMed Corporation
  • Globus Medical, Inc.
  • Integra Lifesciences Corporation
  • Lattice Biologics Ltd.
  • Organogenesis, Inc.
  • Osiris Therapeutics, Inc.
  • Straumann
  • Xtant Medical
  • Zimmer Biomet Holdings, Inc.
Frequently Asked Questions about the Global Market for Soft Tissue Allografts

What is the estimated value of the Global Market for Soft Tissue Allografts?

The Global Market for Soft Tissue Allografts was estimated to be valued at $4.3 Billion in 2020.

What is the growth rate of the Global Market for Soft Tissue Allografts?

The growth rate of the Global Market for Soft Tissue Allografts is 4.9%, with an estimated value of $6.0 Billion by 2027.

What is the forecasted size of the Global Market for Soft Tissue Allografts?

The Global Market for Soft Tissue Allografts is estimated to be worth $6.0 Billion by 2027.

Who are the key companies in the Global Market for Soft Tissue Allografts?

Key companies in the Global Market for Soft Tissue Allografts include Alliqua BioMedical, Inc., Arthrex, Inc., B. Braun Melsungen AG, BARD, A Becton, Dickinson Company, ConMed Corporation, Globus Medical, Inc., Integra Lifesciences Corporation, Lattice Biologics Ltd. and Osiris Therapeutics, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alliqua BioMedical, Inc.
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • ConMed Corporation
  • Globus Medical, Inc.
  • Lattice Biologics Ltd.

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • REST OF EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Alliqua BioMedical, Inc.
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • ConMed Corporation
  • Globus Medical, Inc.
  • Integra Lifesciences Corporation
  • Lattice Biologics Ltd.
  • Organogenesis, Inc.
  • Osiris Therapeutics, Inc.
  • Straumann
  • Xtant Medical
  • Zimmer Biomet Holdings, Inc.
Note: Product cover images may vary from those shown